Opus Genetics (IRD) Cash from Investing Activities Growth (5y) (2015 - 2024)
Opus Genetics (IRD) Cash from Investing Activities Growth (5y) (2015 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
63.81% |
| Dec 31, 2021 |
-15.11% |
| Dec 31, 2020 |
16.28% |
| Dec 31, 2019 |
43.95% |
| Sep 30, 2019 |
16.50% |
| Jun 30, 2019 |
109.08% |
| Mar 31, 2019 |
-190.39% |
| Dec 31, 2018 |
45.25% |
| Sep 30, 2018 |
200.92% |
| Jun 30, 2018 |
53.02% |
| Mar 31, 2018 |
86.18% |
| Dec 31, 2017 |
-28.49% |
| Sep 30, 2017 |
40.53% |
| Jun 30, 2017 |
-44.23% |
| Mar 31, 2017 |
35.39% |
| Dec 31, 2016 |
25.48% |
| Sep 30, 2016 |
-59.60% |
| Jun 30, 2016 |
29.53% |
| Mar 31, 2016 |
23.67% |
| Dec 31, 2015 |
-31.94% |
